Yanbin Liu
- Topics
- SARS-CoV-2 and COVID-19 Research (4 papers)COVID-19 Clinical Research Studies (3 papers)Adipokines, Inflammation, and Metabolic Diseases (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yanbin Liu
29 papers receiving 354 citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 80
- Surgery 61
- Infectious Diseases 59
- Immunology 53
- Cardiology and Cardiovascular Medicine 52
Countries citing papers authored by Yanbin Liu
This map shows the geographic impact of Yanbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Liu more than expected).
Fields of papers citing papers by Yanbin Liu
This network shows the impact of papers produced by Yanbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Liu. The network helps show where Yanbin Liu may publish in the future.
Co-authorship network of co-authors of Yanbin Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Yanbin Liu. A scholar is included among the top collaborators of Yanbin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanbin Liu. Yanbin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 39 | |
| 10 | 1 | |
| 11 | 13 | |
| 12 | 3 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | 7 | |
| 16 | 44 | |
| 17 | 43 | |
| 18 | 6 | |
| 19 | 10 | |
| 20 | 51 |
About Yanbin Liu
Yanbin Liu is a scholar working on Infectious Diseases, Internal Medicine and Developmental Neuroscience, having authored 33 papers that have together received 362 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Infectious Diseases (59 citations), Immunology (53 citations) and Pharmaceutical Science (14 citations). Yanbin Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Weijun Tong, Tan Xu, Qiang Fu, Haidong Xu, Yonghong Zhang, Hongmei Li, Zhao Li, Zhuang Liu, Wenjun Zhu and Qian Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biomaterials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.